Hans Vrielink

Divergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients

Anna E. Oja, Anno Saris, Cherien A. Ghandour et al. · European Journal of Immunology · 2020 · 145 citations · Full text

Adverse events in apheresis: An update of the WAA registry data

M. Mörtzell Henriksson, Elizabeth Newman, Volker Witt et al. · Transfusion and Apheresis Science · 2016 · 137 citations · Full text

HTLV-I/II prevalence in different geographic locations

Hans Vrielink · Transfusion Medicine Reviews · 2003 · 87 citations

Virus Epidemiology, Htlv-i/ii Prevalence, Epidemiologic Method +2

Reliability of the third‐generation recombinant immunoblot assay for hepatitis C virus

M. Damen, Hans L. Zaaijer, H. T. M. Cuypers et al. · Transfusion · 1995 · 79 citations

Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19

Erik H Vogelzang, Floris C. Loeff, Ninotska I. L. Derksen et al. · The Journal of Immunology · 2020 · 79 citations · Full text